Back to search

Article

Advancements in cardiac regenerative therapy: Scalable human iPSC-derived cardiomyocyte differentiation and maturation

2025-01-08

Abstract excerpt

The demand for mass production of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is escalating, driven by their potential to revolutionize cardiac regenerative therapies. The development of large-scale production protocols for iPSC-CMs is crucial to attain their therapeutic potential, enabling the treatment of millions of patients’ worldwide suffering from cardiovascular diseases. However, the sca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
83e9f009-2918-562b-94d6-a9dfd881c762
DOI
10.36922/gtm.5745
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Advancements in cardiac regenerative therapy: Scalable human iPSC-derived cardiomyocyte differentiation and maturationDOI 10.36922/gtm.5745
Select a neighboring publication to make it the new centre.